RLF Wheat Trial Confirms Profitability and Market Potential
| Stock | RLF Agtech Ltd (RLF.ASX) |
|---|---|
| Release Time | 6 Mar 2026, 8:23 a.m. |
| Price Sensitive | Yes |
RLF Wheat Trial Confirms Profitability and Market Potential
- Proven Profitability: RLF's integrated crop nutrition program achieved an average of $212 per hectare net margin and an average 149% Return on Investment (ROI) in wheat
- Targeting Key Market: Results validate RLF's economic solution for 'constrained soils' across Australia's 12-14 million hectares of wheat
- Supporting Adoption: Commercial validation provides strong evidence to assist RLF's sales teams and distribution partners in accelerating product adoption
RLF AgTech Ltd (ASX: RLF) conducted a broadacre wheat field trial in 2025 at Oldbury, Western Australia, to compare its Complete Crop Nutrition Program (CCNP), an integrated seed priming and foliar nutrition program, against standard farmer fertiliser practice across four distinct soil types. Under a favourable growing season, the CCNP delivered strong agronomic performance and economic returns across all soil types. Yield increases ranged from 11.3% to 63.0%, with an average increase of approximately 32% across the trial site. Economic analysis indicated an average net margin improvement of approximately $212 per hectare, with the strongest response observed on the nutrient-constrained Orange soil, where yields increased from 1.88 t/ha to 3.07 t/ha (63% uplift) and generated a 267% return on investment. The trial also demonstrated improvements in rainfall use efficiency, with the CCNP treatment converting seasonal rainfall into grain more effectively than standard fertiliser practice. These outcomes highlight the potential for RLF's integrated crop nutrition technologies to improve productivity across a range of soil conditions commonly encountered in Australian wheat production systems. The consistent yield, quality and economic improvements observed across multiple soil zones demonstrate the commercial potential of the CCNP approach and are expected to support broader adoption of advanced crop nutrition strategies in Australian broadacre agriculture.
The results from the 2025 Oldbury wheat trial provide a strong, field-based foundation for the continued commercial rollout of RLF's crop nutrition programs across the Australian broadacre sector. The consistent yield improvements, grain quality outcomes and positive economic returns demonstrated across multiple soil zones provide practical agronomic data that supports grower confidence in the commercial application of RLF's Complete Crop Nutrition Program. These results are now being utilised by the Company's commercial team and distribution partners as part of ongoing engagement with growers, agronomists and retail networks across Australia, and are expected to support further adoption of RLF's crop nutrition technologies across Australian wheat production systems.